ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

NCI Plans Conference To Reconsider Breast Cancer Screening In women 40-49

April 19, 1996

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011